8-KItem 2.02 · Results of OperationsItem 9.01 · Financial Statements
DEXCOM INC (DXCM)

DEXCOM filed an 8‑K on Jan 12, 2026 furnishing exhibits: press releases dated Jan 12, 2026 (Ex.99.1) and…

Filed with the SEC on · Summarized by InvestorsBot

DEXCOM filed an 8‑K on Jan 12, 2026 furnishing exhibits: press releases dated Jan 12, 2026 (Ex.99.1) and Jan 7, 2026 (Ex.99.2), plus Cover Page Inline XBRL (Ex.104). Review the releases for substantive details. $DXCM 📰 #8K #SEC #medtech

Exhibit highlight: Ex.104 is the Interactive Inline XBRL cover page — machine‑readable financial/cover data included for analysts and investors. $DXCM 📊 #XBRL #investing

Filing signed Jan 12, 2026 by Jereme M. Sylvain, EVP & CFO, certifying the submission. Item 9.01 only lists exhibits (99.1, 99.2, 104). $DXCM ✍️ #SEC #8K

Read the original filing on SEC EDGAR

Get summaries like this in your inbox every morning

Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.

Subscribe free

More from DEXCOM INC

Dexcom Executive Chair Kevin Sayer sells $2.0M in stock

Form 4 · Insider Trade · July 21, 2026

DexCom files 8-K (Item 9.01): Exhibit 10.1 — Letter Agreement dated Feb 27, 2026 between DexCom, Inc.

8-K · March 2, 2026

Kevin R.

8-K · March 2, 2026

Dexcom filed Form 8‑K on Feb 26, 2026: Item 9.01 lists Exhibit 99.1 (press release dated Feb 26, 2026) and…

8-K · February 26, 2026

Dexcom ($DXCM) announced on Feb 26, 2026 the appointment of Mr.

8-K · February 26, 2026

Dexcom Board expands to 12; appointed Albert F.

8-K · February 26, 2026